Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study - Wikidata - awgldk - TriplyDB

Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study

Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study

http://www.wikidata.org/entity/Q34988296

about

Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies.Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.Migrant women living with HIV in Europe: are they facing inequalities in the prevention of mother-to-child-transmission of HIV?: The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord.Pregnancy and linkage to care among women diagnosed with HIV infection in 61 CDC-funded health departments in the United States, 2013.HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.Complications and Route of Delivery in a Large Cohort Study of HIV-1-Infected Women-IMPAACT P1025.Reported Church Attendance at the Time of Entry into HIV Care is Associated with Viral Load Suppression at 12 Months.Evaluation of universal versus genotype-guided efavirenz dose reduction in pregnant women using population pharmacokinetic modelling.Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States.Evaluating outcomes of mother-infant pairs using dolutegravir for HIV treatment during pregnancy

P2860

Q28546081-AA818EDF-279D-43CB-9354-053E64171FE4 Q33629439-427D2062-4A59-4374-9613-93CA96E041AB Q37199763-172144CB-6F5E-42BF-9C9D-48FEAB1E2CDB Q38816671-47DE2AAE-5EBD-446D-9335-41049C7ED3E8 Q38993301-1C39DAB0-C33F-438B-8AA8-E68ECF6C9494 Q39648148-19B29C8B-A7BB-407D-A1D2-0C380E96616E Q39848285-4A4498A2-275C-4530-8FA4-18B844D7A34D Q40769935-C0F78094-7438-4BC5-A7DF-0A02409F1220 Q46460183-69E59FA2-75EA-4DAC-B550-B8BC24D058EA Q54239556-89424E0A-94A4-4E26-A606-E802653144B0 Q58767934-2C3C434D-4C5F-4FAC-BB53-0A5326612FE8

P2860

Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study

http://www.wikidata.org/entity/Q34988296

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Factors associated with lack o ...... women with HIV: a cohort study

@ast

Factors associated with lack o ...... women with HIV: a cohort study

@en

Factors associated with lack o ...... women with HIV: a cohort study

@nl

type

label

Factors associated with lack o ...... women with HIV: a cohort study

@ast

Factors associated with lack o ...... women with HIV: a cohort study

@en

Factors associated with lack o ...... women with HIV: a cohort study

@nl

prefLabel

Factors associated with lack o ...... women with HIV: a cohort study

@ast

Factors associated with lack o ...... women with HIV: a cohort study

@en

Factors associated with lack o ...... women with HIV: a cohort study

@nl

P1433

Q34988296-4972AF14-BE92-4FB7-B9C4-24A04B3EC83D

P1476

Q34988296-1A88441D-0794-4128-80A1-D07A63A5E167

P2093

Q34988296-073DE27B-6D66-4F31-9A7F-44F001EEA324

Q34988296-07C1ADBB-AA2B-45BB-A8E2-8EE2BD50B92E

Q34988296-3905A1F1-7D74-4CD0-9C97-DBD94E88BBB0

Q34988296-4F4974C3-D119-4D35-887B-648FA52A8CB2

Q34988296-702F58F0-FA15-44D9-BE6B-84781883034A

Q34988296-7E980769-1F36-4D5B-8843-2893FAD446BE

Q34988296-ADD92C49-152C-41B8-A800-303630C1D068

Q34988296-B23BCDEE-88B7-42F7-A3D4-034B5A3C5756

P2860

Q34988296-00FED20D-E9AD-4A8C-8B16-1594A9F25D7B

Q34988296-0551FADC-FB3F-4C9A-9401-4DBEBE2A17D7

Q34988296-091616BB-DE3B-4E43-95EB-8E408A36B409

Q34988296-104A956E-2B00-4EDC-A87C-5FCB94E95F75

Q34988296-10DD9F29-2863-40FD-89C4-4B1CC987CCBB

Q34988296-12769A64-4FFB-474B-A48E-3B347F9C6B8E

Q34988296-35ED3C56-2B7F-48AA-A751-5CAE359EFC6A

Q34988296-4D9EFDB7-8BE5-471C-B34B-C27D02967C1D

Q34988296-5708FC0F-96F0-4DFD-AF5B-68F384847548

Q34988296-5C6E5BEA-C288-4D58-8C86-620FCA2EEC9A

P304

Q34988296-3ABA4E7B-53D1-4AD5-956F-61CFB244921C

P31

Q34988296-50D7BE55-FD55-4E4D-AE39-DB1BFA9E50B8

P356

Q34988296-D57C9746-7E38-439C-B3DE-959C6D2A52DE

P407

Q34988296-2800FB13-9EA1-4EAD-9AB6-BFCF6B3F10A9

P433

Q34988296-DDAFD779-1059-4D96-A761-B6F1E2102A84

P478

Q34988296-55C8DA85-10C9-4701-A561-3214F1CB6940

P50

Q34988296-55752304-9142-4B5F-912F-B9CF27C2FC1D

P577

Q34988296-FA9E41D8-E492-4F3F-8BBE-F66C5F196061

P698

Q34988296-A5B93D85-45FF-4072-ADE9-95C52DFE70A1

P921

Q34988296-D0946427-BD0D-4AAF-9C32-B409829E4943

P932

Q34988296-C3B9A0A9-6EA8-4BBE-BC84-CBFB08739193

P356

P1433

Annals of Internal Medicine

P1476

Factors associated with lack o ...... women with HIV: a cohort study

@en

P2093

Alice Stek

http://www.w3.org/2001/XMLSchema#string

Arlene Bardeguez

http://www.w3.org/2001/XMLSchema#string

David E Shapiro

http://www.w3.org/2001/XMLSchema#string

Deborah Kacanek

http://www.w3.org/2001/XMLSchema#string

Elizabeth Livingston

http://www.w3.org/2001/XMLSchema#string

Erin Leister

http://www.w3.org/2001/XMLSchema#string

Michael D Hughes

http://www.w3.org/2001/XMLSchema#string

Ruth Tuomala

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

Effect of early versus deferred antiretroviral therapy for HIV on survival.

The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns.

Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study.

Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy)

The interplay of sociodemographic factors on virologic suppression among a U.S. outpatient HIV clinic population

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States.

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

P304

90-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/M13-2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25599347

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4299931

http://www.w3.org/2001/XMLSchema#string